technology tandem mass spectrometry: Live & Latest News Updates : Vimarsana.com

Global Injection Molding Machine Market Size to Reach USD 25.23 Billion in 2032 | Emergen Research

Global Endocrine Testing (FSH, Insulin) Market Report 2023: Market to Reach $21.42 Billion by 2030 - Digital Health Solutions and At-Home Testing Boosting Growth

/PRNewswire/ -- The "Endocrine Testing Market Size, Share & Trends Analysis Report By Test Type (FSH, Insulin), By Technology (Tandem Mass Spectrometry,...

Global Endocrine Testing (FSH, Insulin) Market Trends

Dublin, Oct. 24, 2023 (GLOBE NEWSWIRE) -- The

Global Embolic Protection Devices Market Size to Reach USD 1,242.9 Million in 2032 | Emergen Research

How Will the Proteomics Market Transform Itself into a USD

Significant investments in discovery of biomarkers in proteomics is a key factor driving Proteomics market revenue growth....

Esoteric Testing Market worth $36.3 billion by 2026 - Exclusive Report by MarketsandMarkets™

Esoteric Testing Market worth $36.3 billion by 2026 - Exclusive Report by MarketsandMarkets

Immunoassay Market worth $39.0 billion by 2026 - Exclusive Report by MarketsandMarkets

Immunoassay Market worth $39.0 billion by 2026 - Exclusive Report by MarketsandMarkets "Immunoassay Market by Product (Reagents & Kits, Analyzers), Technology (ELISA, IFA, Rapid Tests, Radio Immunoassay), Specimen (Blood, Saliva, Urine), Application (Infectious Diseases, Oncology), End User (Hospitals & Clinics) - Global Forecast to 2026", published by MarketsandMarkets, the global Immunoassay Market is projected to reach USD 39.0 billion by 2026 from USD 28.4 billion in 2021, at a CAGR of 6.6% during the forecast period. Browse in-depth TOC on Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=436 The surging incidence of chronic and infectious diseases, technological advancements of immunoassay products, and their massive adoptions are the major factors driving the growth of the market.

Immunoassay Market worth $39.0 billion by 2026 - Exclusive Report by MarketsandMarkets™

The surging incidence of chronic and infectious diseases, technological advancements of immunoassay products, and their massive adoptions are the major factors driving the growth of the market. In 2020, reagents & kits accounted for the largest share of the market and is also expected to grow at the highest CAGR during the forecast period. Based on the product, the immunoassay market is segmented into reagents & kits and analyzers. In 2020, the reagents & kits segment accounted the largest share of the market. This segment is also expected to register the highest CAGR during the forecast period. The large share of this segment is attributed to their repetitive purchase and massive consumption for various diagnostic purposes.

The Worldwide Newborn Screening Industry is Projected to Reach $1.3 Billion by 2026 at a CAGR of 8.3% from 2021

Share this article Share this article ResearchAndMarkets.com's offering. The global newborn screening market size is projected to reach USD 1.3 billion by 2026 from USD 0.9 billion in 2021, at a CAGR of 8.3% during the forecast period. The rapid growth in the newborn screening rate, the increasing prevalence of newborn metabolic, hormonal and genetic diseases, and favourable government policies are driving the growth of newborn screening. Newborn Disorder screening instruments segment accounted for the largest share of the newborn screening market in 2019. Based on instrument, the newborn screening market is segmented into newborn disorder screening instruments, newborn hearing screening instruments, and pulse oximeters. Newborn disorder screening instruments accounted for the largest share in 2019. These instruments can screen for the majority of newborn disorders and thus see the highest demand. Government support and the implementation of newborn screening programs also support the market.